XGEN PHARMS FDA Approval ANDA 063206

ANDA 063206

XGEN PHARMS

FDA Drug Application

Application #063206

Application Sponsors

ANDA 063206XGEN PHARMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION50MG/VIAL0AMPHOTERICIN BAMPHOTERICIN B

FDA Submissions

ORIG1AP1992-04-29
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1995-01-17
LABELING; LabelingSUPPL3AP1995-03-15
LABELING; LabelingSUPPL4AP1996-08-19
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1998-09-18
LABELING; LabelingSUPPL6AP1999-10-12
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-02-11
LABELING; LabelingSUPPL16AP2009-02-17
LABELING; LabelingSUPPL17AP2010-03-05

Submissions Property Types

SUPPL2Null0
SUPPL5Null0
SUPPL7Null0
SUPPL17Null7

CDER Filings

XGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 63206
            [companyName] => XGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMPHOTERICIN B","activeIngredients":"AMPHOTERICIN B","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"Yes"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AMPHOTERICIN B","submission":"AMPHOTERICIN B","actionType":"50MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.